Loren Kendis
Internal Medicine · Mayfield Village, OHNPI 1861431348
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 175 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $767 and has fallen 84.0% since, to $122 in 2023.
Across 175 payments — averaging $15.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$298
- AstraZeneca$282
- Lilly USA, LLC$245
- AbbVie$180
- Boehringer Ingelheim$155
- Novo Nordisk$142
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,660100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 20 | $298 |
| AstraZeneca | 19 | $282 |
| Lilly USA, LLC | 16 | $245 |
| AbbVie | 12 | $180 |
| Boehringer Ingelheim | 10 | $155 |
| Novo Nordisk | 10 | $142 |
| Pfizer | 7 | $127 |
| Biohaven Pharmaceuticals, Inc. | 9 | $120 |
| Grifols USA, LLC | 7 | $110 |
| Merck | 7 | $109 |
| E.r. Squibb & Sons, L.L.C. | 7 | $107 |
| Nestle Healthcare Nutrition Inc. | 6 | $101 |
| Novartis | 6 | $98 |
| Radius Health, Inc. | 4 | $74 |
| Sanofi-aventis U.S. LLC | 5 | $72 |
| Amarin Pharma, Inc. | 4 | $70 |
| Johnson & Johnson | 5 | $68 |
| Abbott | 3 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $47 |
| EMD Serono, Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| GSK | 2 | $26 |
| Astellas Pharma US Inc | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Seqirus USA Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$2,660 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 11 | $86 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Mayfield Village
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.